Dare Bioscience, Inc. Net Rentable Area
Dare Bioscience, Inc. (DARE) had Net Rentable Area of 3.17 thousand sqft as of 2018-07-01, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:NetRentableArea · last filed 2026-08-13
- 2018-07-01: Net Rentable Area 3.17K sqft.
| Period end | Net Rentable Area |
|---|---|
| 2018-07-01 | 3.17K sqft 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |